It’s one of the most well-known tenets of modern medicine: An aspirin a day keeps the doctor away. But according to a trio of studies published Sunday in the New England Journal of Medicine, a daily low-dose aspirin regimen provides no significant health benefits for healthy older adults. Instead, it may cause them serious harm.
The maker of Taytulla birth-control treatment issued a nationwide recall in the United States on Tuesday over concerns that misplaced capsules in pill packs could cause unintended pregnancies.
The first medicine designed to prevent migraines was recently approved by the Food and Drug Administration.
Ketamine, typically considered a recreational drug, has been shown to help people suffering from depression who haven’t responded to other medications, a new study has shown.
Every 65 seconds, someone in the United States is diagnosed with Alzheimer's. There are studies worldwide in the fight against the deadly disease. A number of them at Yale School of Medicine.
A study released in the New England Journal of Medicine revealed that a new class of drugs could be a game changer for people living with chronic migraines.
A timely announcement from the FDA — on the heels of the deadliest flu season in four decades and at the start of a new one.
One of every 70 children and one of every 160 adults is allergic to peanuts, making it the most common food allergy.
U.S. Senator Richard Blumenthal asked the Food and Drug Administration to regulate the ingredient found in cannabis known as Cannabidiol, or CBD, on Tuesday morning.
There’s a new class of drugs designed to prevent migraines-the first of their kind! The first medicine designed to prevent migraines was recently approved by the Food and Drug Administration, ushering in what is being called a new era in treatment for people who suffer from debilitating headaches. The drug, Aimovig, is made by Amgen […]